Chemomab Therapeutics OverviewChemomab Therapeutics Net Income
Profitability analysis for CMMB.
Quarterly Net Income
-$1.77M
↑ 46.79% YoY
As of Mar 2026
Annual Net Income (TTM)
-$7.45M
↑ 44.33% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...